Marcus Neubauer
Overview
Explore the profile of Marcus Neubauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waterhouse D, Ward P, Arnal S, Neubauer M, Drosick D, Davies D, et al.
JCO Oncol Pract
. 2023 May;
19(6):e951-e956.
PMID: 37126768
Purpose: Non-small-cell lung cancer (NSCLC), the leading cause of cancer death in the United States, accounts for 85% of all lung cancer cases. Biomarker testing is an integral part of...
2.
Robert N, Espirito J, Chen L, Nwokeji E, Karhade M, Evangelist M, et al.
Lung Cancer
. 2022 Mar;
166:197-204.
PMID: 35313244
Objectives: The MYLUNG (Molecularly Informed Lung Cancer Treatment in a Community Cancer Network) consortium pragmatic study assessed real-world biomarker testing rates and turnaround times within a large community-based oncology network....
3.
Hoverman J, Ginsburg A, Wilfong L, Neubauer M
JCO Oncol Pract
. 2021 Jul;
17(8):463-464.
PMID: 34264773
No abstract available.
4.
Telemedicine in Community Cancer Care: How Technology Helps Patients With Cancer Navigate a Pandemic
Patt D, Wilfong L, Toth S, Broussard S, Kanipe K, Hammonds J, et al.
JCO Oncol Pract
. 2021 Jan;
17(1):e11-e15.
PMID: 33434450
COVID-19 places unprecedented demands on the oncology ecosystem. The extensive pressure of managing health care during the pandemic establishes the need for rapid implementation of telemedicine. Across our large statewide...
5.
Neubauer M, Jones B
Am J Manag Care
. 2021 Jan;
26(8 Spec No.):SP251-SP252.
PMID: 33395233
COVID-19 has created a significant distraction from normal practice operations. The uncertainty that comes along with the pandemic is a huge worry, and can distract from practice transformation.
6.
Walker B, Frytak J, Hayes J, Neubauer M, Robert N, Wilfong L
JAMA Netw Open
. 2020 May;
3(5):e205165.
PMID: 32421185
Importance: Health insurers reimburse clinicians in many ways, including the ubiquitous fee-for-service model and the emergent shared-savings models. Evidence on the effects of these emergent models in oncological treatment remains...
7.
Neubauer M
Am J Manag Care
. 2020 Feb;
26(2 Spec No.):SP60-SP61.
PMID: 32078282
No abstract available.
8.
Kline R, Brown M, Buescher N, Cox J, Horenkamp E, Hoverman R, et al.
J Natl Cancer Inst
. 2019 May;
111(8):764-771.
PMID: 31050766
The Oncology Care Model (OCM) is a 5-year model developed and tested by the Centers for Medicare & Medicaid Services that uses an episode-based payment model triggered by the receipt...
9.
Nardi E, McCanney J, Winckworth-Prejsnar K, Schatz A, Adelson K, Neubauer M, et al.
J Natl Compr Canc Netw
. 2018 May;
16(5):473-478.
PMID: 29752321
Quality measurement in oncology is increasing in significance as payment schemes shift from volume to value. As demand for quality measures increases, challenges in the development of quality measures, standardization...
10.
Seiden M, Neubauer M, Verrilli D
Am J Manag Care
. 2017 Mar;
23(2 Spec No.):SP69-SP77.
PMID: 28298130
No abstract available.